XOMA Royalty (XOMA) Gross Margin (2011 - 2013)

XOMA Royalty (XOMA) reported Gross Margin of 99.71% for Q2 2013, up 58.0% on a YoY basis from 63.11% in Q2 2012, and little changed sequentially from 99.51% in Q1 2013.

XOMA Royalty (XOMA) Gross Margin (2011 - 2013) Analysis & Trends

XOMA Royalty (XOMA) has 3 years of Gross Margin data on file, last reported at 99.71% in Q2 2013.

  • For the quarter ending Q2 2013, Gross Margin rose 58.0% year-over-year to 99.71%; the trailing twelve-month figure through Jun 2013 stood at 99.59% (down 23.0% YoY), and the FY2012 full-year result was 97.5%, down 250.0% from the prior year.
  • Gross Margin steadied at 99.71% in Q2 2013, from 99.51% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 100.0% in Q2 2011 to a low of 99.13% in Q2 2012.
  • A 3-year average of 99.72% and a median of 99.71% in 2013 frame the typical range for Gross Margin.
  • Across the five-year window, Gross Margin tumbled 87 bps in 2012 and soared 58 bps in 2013, its largest moves.
  • Tracing XOMA's Gross Margin over 3 years: stood at 100.0% in 2011, then dropped by 0 bps to 99.55% in 2012, then rose by 0 bps to 99.71% in 2013.
  • Business Quant data shows XOMA's Gross Margin at 99.71% in Q2 2013, 99.51% in Q1 2013, and 99.55% in Q4 2012.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 88.95%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 86.85%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 91.79%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 90.68%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 XOMA Royalty 478.42 Mn 412.34 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2013 99.71%
Mar 31, 2013 99.51%
Dec 31, 2012 99.55%
Sep 30, 2012 99.61%
Jun 30, 2012 99.13%
Mar 31, 2012 100.00%
Dec 31, 2011 100.00%
Sep 30, 2011 100.00%
Jun 30, 2011 100.00%